Manufacturing: what US businesses sold for
What is my manufacturing business worth?
Manufacturing businesses in the United States sold for a median of 9.0 times EBITDA (50+ deals of US$10 million to US$500 million, deals announced 2017 to 2026, the last ten years). The middle half of those deals ran from 6.5 to 12.0 times.
Deals updated October 2026
By deal size
Each size band on its own. A band with too few deals shows no figure.
- US$10 million to US$500 million
- Median 9.0 times EBITDA. The middle half of deals ran from 6.5 to 12.0 times (50+ deals of US$10 million to US$500 million, deals announced 2017 to 2026, the last ten years).
- US$500 million to US$2 billion
- Median 11.5 times EBITDA. The middle half of deals ran from 9.5 to 13.5 times (100+ deals of US$500 million to US$2 billion, deals announced 2017 to 2026, the last ten years).
- All deals
- Median 11.5 times EBITDA. The middle half of deals ran from 8.5 to 14.0 times (300+ deals of all sizes, deals announced 2017 to 2026, the last ten years).
Within this industry
Each sub-industry with enough deals, at its own size band.
- Aerospace and defense: Median 11.0 times EBITDA. The middle half of deals ran from 7.0 to 13.5 times (10+ deals of US$10 million to US$500 million, deals announced 2017 to 2024, the last ten years).
- Apparel manufacturing: Median 7.0 times EBITDA. The middle half of deals ran from 6.0 to 7.5 times (10+ deals of US$10 million to US$500 million, deals announced 2010 to 2017, every year we hold).
- Automotive parts: Median 6.0 times EBITDA. The middle half of deals ran from 5.0 to 7.0 times (20+ deals of US$10 million to US$500 million, deals announced 1999 to 2020, every year we hold).
- Building materials: Median 10.5 times EBITDA. The middle half of deals ran from 8.0 to 11.5 times (10+ deals of US$10 million to US$500 million, deals announced 2010 to 2022, every year we hold).
- Chemicals and plastics: Median 10.5 times EBITDA. The middle half of deals ran from 10.0 to 11.5 times (10+ deals of US$10 million to US$500 million, deals announced 2017 to 2022, the last ten years).
- Consumer products manufacturing: Median 9.5 times EBITDA (5+ deals under US$2 billion, deals announced 2012 to 2022, every year we hold). The group is small, so no middle half is shown.
- Electronics manufacturing services: Median 7.5 times EBITDA (5+ deals of US$10 million to US$500 million, deals announced 2011 to 2018, every year we hold). The group is small, so no middle half is shown.
- Food and beverage manufacturing: Median 8.5 times EBITDA. The middle half of deals ran from 6.5 to 13.0 times (10+ deals of US$10 million to US$500 million, deals announced 2017 to 2026, the last ten years).
- Gaming equipment: Median 7.5 times EBITDA (5+ deals of all sizes, deals announced 2015 to 2025, every year we hold). The group is small, so no middle half is shown.
- Industrial and engineered products: Median 8.0 times EBITDA. The middle half of deals ran from 7.0 to 9.0 times (10+ deals of US$10 million to US$500 million, deals announced 2017 to 2024, the last ten years).
- Life science tools and diagnostics: Median 20.0 times EBITDA (5+ deals of all sizes, deals announced 2013 to 2025, every year we hold). The group is small, so no middle half is shown.
- Medical devices: Median 14.0 times EBITDA (5+ deals of US$10 million to US$500 million, deals announced 2015 to 2019, every year we hold). The group is small, so no middle half is shown.
- Metals and metal products: Median 7.0 times EBITDA (5+ deals of all sizes, deals announced 2006 to 2020, every year we hold). The group is small, so no middle half is shown.
- Packaging: Median 8.0 times EBITDA. The middle half of deals ran from 6.5 to 10.0 times (10+ deals under US$2 billion, deals announced 2011 to 2026, every year we hold).
- Personal care and cosmetics: Median 15.0 times EBITDA (5+ deals under US$2 billion, deals announced 2010 to 2022, every year we hold). The group is small, so no middle half is shown.
- Pharmaceutical and health products: Median 11.0 times EBITDA. The middle half of deals ran from 9.5 to 15.0 times (10+ deals of US$10 million to US$500 million, deals announced 2010 to 2024, every year we hold).
- Pulp and paper: Median 6.0 times EBITDA (5+ deals of all sizes, deals announced 2014 to 2021, every year we hold). The group is small, so no middle half is shown.
- Scientific instruments: Median 13.5 times EBITDA (5+ deals of all sizes, deals announced 2010 to 2022, every year we hold). The group is small, so no middle half is shown.
- Other businesses in this industry: Median 8.0 times EBITDA. The middle half of deals ran from 6.0 to 10.5 times (10+ deals of US$10 million to US$500 million, deals announced 2017 to 2024, the last ten years).
Pick an industry and a size. Enter your yearly earnings to see them at the multiples those businesses sold at. Nothing you enter leaves this page.
This is not a valuation. It is arithmetic on reported deals. A buyer sets the price after testing your earnings, customers and plan.
Manufacturing: what buyers paid
In Manufacturing, US deals in our database sold at a median of 9.0 times EBITDA. The middle half sold at 6.5 to 12.0 times.
50+ deals, announced 2017 to 2026. These are deals from the last ten years.
These are US deals in our database with a published value. Most come from bankers' opinions filed with US mergers, so they lean to larger businesses.
How these figures are made. Where these deals come from, and what they leave out, is on the method page.
These are US deals in our database with a published value. Most come from bankers' opinions filed with US mergers, so they lean to larger businesses.
Built by Andrew Wilson and Claire Grego, former partners of strategy consulting firms. Between them they have worked at Bain, BCG, Monitor Deloitte and Strategy&.